Kyrgyzstan's health ministry. It approved the country's cancer strategy for 2021 to 2025, and the public health insurer and the medicines regulator both sit under it.
By order No. 1019 of 28 July 2021, issued when it was the Ministry of Health and Social Development, the Ministry approved the Strategy for the control and prevention of oncological diseases in the Kyrgyz Republic for 2021 to 2025 and its action plan; the scanned order is posted on the ICCP portal. The strategy covers prevention, the introduction of HPV vaccination, pilot screening centres for cervical and breast cancer, radiotherapy, palliative care and a population-based cancer registry beginning in Chuy region. The order told the director of the National Center of Oncology and Hematology to draft the rules for a coordination council. The Mandatory Health Insurance Fund and the Department of Medicines and Medical Devices each describe themselves on their own sites as bodies under the Ministry. WHO's account of the HPV vaccine's introduction in 2022 describes a government programme that WHO supported, with awareness work done in collaboration with the Ministry. OnCo could not connect to the Ministry's own site on 16 November 2026 and found no strategy for the years after 2025. The coordinates are an approximate Bishkek city point, not the building.
This paper, which draws on the country's own reports, puts new cancers at about 6,650 a year. IARC's modelled estimate is higher, which is consistent with some cancers never being registered, though neither figure is exact.
The authors argue for scaling up cervical screening based on HPV testing alongside vaccination. WHO's 2021 profile recorded no national cervical screening programme in Kyrgyzstan.
About six in ten of the liver cancers studied (348 of 572, counting the 17 people with both infections once) were attributed to hepatitis B or C, infections that can be prevented by vaccination or treated. The authors call for earlier testing and treatment. Liver cancer is the third commonest cause of cancer death in IARC's 2024 estimate for Kyrgyzstan.
Registered breast cancer is commonest around the capital, where diagnosis is most available, and rising in the south. A registry counts what is diagnosed and reported, so lower regional rates may partly reflect cancers that were not found.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/